BioPharma Conference

The 2022 ASAP BioPharma Conference will be here before you know it. While you're there, wouldn't you like to take the stage and share your alliance stories and successes with your peers? The spotlight is waiting...and the call for topics runs through May 20. Continue Reading

Looking ahead at your career path? It might help to look back, forward, and all around you. Some of our experienced biopharma veterans weighed in on what makes a good career planning process, the importance of getting the right people on your "team," and knowing your "what" and your "why." Continue Reading

Dicerna Pharmaceuticals put together a rigorous survey of its own employees and those of its partners to solicit undisguised, straightforward commentary on its people and practices—the good, the bad, and the ugly. The exercise was a "heavy lift," said one 2021 ASAP BioPharma Conference presenter. Continue Reading

What happens when your company is acquired by a larger company? And what if it's your partner that gets acquired? The show must go on, and the alliance must continue, but it takes a "maestro" of the art and science of alliance management to navigate through an acquisition and integration. Continue Reading

A recent ASAP BioPharma Conference roundtable found that partners are splitting up sales duty by country, the biopharma partnering ecosystem is getting larger and more complex, internal company transformations are impacting alliances, and not enough attention is being paid to exit strategies. Continue Reading

Few people outside of the technology industry have thought to apply the agile framework to their business. Two Cancer Research UK executives told the story of how the organization used it to revamp how it monitored the overall performance of its clinical trial operation. Continue Reading

Alliances are essential to the success of GE Healthcare's Edison Artificial Intelligence (AI) platform, but it couldn’t simply employ “business as usual” partnering practices. Instead, and ecosystem of partners are creating their own "sandboxes.” Continue Reading

The CEO of a device startup shared his team's surprises and alliance lessons learned in this ASAP BioPharma Conference 2021 day two keynote. Continue Reading

Fundamental partnering practices combined with a modern digital platform will boost value realization, operational efficiency, risk management, and strategic agility across the portfolio, according to allianceboard's Digital Alliance Maturity Index. Continue Reading

In biopharma today, it's all about collaboration and putting the patient at the center. Two CEOs discussed how their partnership thrives on openness, trust, and shared goals and how it continually keeps the focus on patient needs. Continue Reading

The 2021 ASAP BioPharma Conference panel “Partnering for Patient Impact” revealed some ways alliance managers can create a patient-focused culture across their portfolios, measure the impact alliances have on patients, and foster innovations that can directly improve patient experiences. Continue Reading

The collaboration between Halozyme and argenx is a powerful combination. The two companies' CEOs will tell how and why it works and why such partnerships are more important than ever in an increasingly patient-centric pandemic world. Continue Reading